Neurogene (NGNE) Current Leases (2018 - 2026)

Neurogene has reported Current Leases for 9 years, with the latest figure at $3.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases changed 0.07% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (changed 0.07% YoY), and the FY2025 full-year result was $3.0 million, up 5548.15% from the prior year.
• Current Leases for Q1 2026 stood at $3.0 million, roughly flat from $3.0 million in the prior quarter.
• The five-year high for Current Leases was $3.1 million in Q2 2025, with the low at $4000.0 in Q3 2023.
• Historically, Current Leases has averaged $1.8 million across 5 years, with a median of $1.5 million in 2023.
• Annual changes were most pronounced in 2023 — Current Leases tumbled 99.7% — and 2024, when it soared 71300.0%.
• Neurogene's Current Leases stood at $24000.0 in 2022, then soared by 10562.5% to $2.6 million in 2023, then slumped by 97.89% to $54000.0 in 2024, then soared by 5548.15% to $3.0 million in 2025, then decreased by 0.39% to $3.0 million in 2026.
• The last three Current Leases figures came in at $3.0 million (Q1 2026), $3.0 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.